Cargando…

Long non-coding RNA HAGLROS facilitates the malignant phenotypes of NSCLC cells via repressing miR-100 and up-regulating SMARCA5

BACKGROUND: Long non-coding RNA (lncRNA) is implicated in the progression of multiple cancers. This study aimed to explore the expression characteristics, biological function and molecular mechanism of lncRNA HAGLROS expression in NSCLC. METHODS: Quantitative real-time polymerase chain reaction (RT-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Li, Zhu, Hongyan, Li, Xiangyang, Ke, Yaoqi, Yang, Shuai, Cheng, Qingping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chang Gung University 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068548/ https://www.ncbi.nlm.nih.gov/pubmed/35307327 http://dx.doi.org/10.1016/j.bj.2020.12.008

Ejemplares similares

Long non‐coding RNA HAGLROS promotes the development of diffuse large B‐cell lymphoma via suppressing miR‐100
por: Shu, Ling, et al.
Publicado: (2021)

HAGLROS knockdown restrained cell proliferation, migration and invasion and facilitated apoptosis in laryngeal cancer via miR‐138‐5p/CLN5 axis
por: Fu, Dehui, et al.
Publicado: (2022)

Correlative analysis of miR-34b and p53 with pathological characteristics of NSCLC
por: Yang, Shuai, et al.
Publicado: (2019)

Long Noncoding RNA HAGLROS Promotes the Malignant Progression of Bladder Cancer by Regulating the miR-330-5p/SPRR1B Axis
por: Xiao, Shiwei, et al.
Publicado: (2022)

Interference of long non-coding RNA HAGLROS inhibits the proliferation and promotes the apoptosis of ovarian cancer cells by targeting miR-26b-5p
por: Zhu, Lin, et al.
Publicado: (2021)

Knockdown of lncRNA HAGLROS inhibits metastasis and promotes apoptosis in nephroblastoma cells by inhibition of autophagy
por: Li, Pugui, et al.
Publicado: (2022)

The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
por: Zeng, Xiangwei, et al.
Publicado: (2023)

Long non-coding RNA HAGLROS facilitates tumorigenesis and progression in hepatocellular carcinoma by sponging miR-26b-5p to up-regulate karyopherin α2 (KPNA2) and inactivate p53 signaling
por: Tang, Gaofeng, et al.
Publicado: (2022)

Long Noncoding RNA HAGLROS Promotes Cell Invasion and Metastasis by Sponging miR-152 and Upregulating ROCK1 Expression in Osteosarcoma
por: Zhou, Kaifeng, et al.
Publicado: (2020)

The miR-100-5p Targets SMARCA5 to Regulate the Apoptosis and Intracellular Survival of BCG in Infected THP-1 Cells
por: Su, Li, et al.
Publicado: (2023)

Retracted: Long Noncoding RNA HAGLROS Promotes Cell Invasion and Metastasis by Sponging miR-152 and Upregulating ROCK1 Expression in Osteosarcoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Tissue-specific SMARCA4 binding at active and repressed regulatory elements during embryogenesis
por: Attanasio, Catia, et al.
Publicado: (2014)

MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5
por: Wang, Haiyang, et al.
Publicado: (2020)

SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution
por: Sun, Shanshan, et al.
Publicado: (2022)

MicroRNA miR-100 Decreases Glioblastoma Growth by Targeting SMARCA5 and ErbB3 in Tumor-Initiating Cells
por: Alrfaei, Bahauddeen M., et al.
Publicado: (2020)

STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy
por: Chen, Jin-Fei, et al.
Publicado: (2018)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Upregulation and the clinical significance of KCNQ1OT1 and HAGLROS lncRNAs in papillary thyroid cancer: An observational study
por: Mutlu Icduygu, Fadime, et al.
Publicado: (2023)

Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2020)

Circ_0010235 Regulates HOXA10 Expression to Promote Malignant Phenotypes and Radioresistance in Non-small Cell Lung Cancer Cells Via Decoying miR-588
por: Zhu, Hongyan, et al.
Publicado: (2022)

Hyperglycemia-Suppressed SMARCA5 Disrupts Transcriptional Homeostasis to Facilitate Endothelial Dysfunction in Diabetes
por: Wang, Ju, et al.
Publicado: (2023)

Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies
por: Pan, Minggui, et al.
Publicado: (2023)

Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)

Correction: Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2022)

SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics
por: Al-Shbool, Ghassan, et al.
Publicado: (2022)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

miR-146a-5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression
por: Huang, Wen-Ting, et al.
Publicado: (2019)

Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
por: Chen, Zhenyao, et al.
Publicado: (2020)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer
por: Xue, Changning, et al.
Publicado: (2022)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

Circular RNA SMARCA5 inhibits gastric cancer progression through targeting the miR-346/ FBXL2 axis
por: Li, Quanying, et al.
Publicado: (2019)

The Emerging Roles of circSMARCA5 in Cancer
por: Qin, Haoyu, et al.
Publicado: (2022)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Interferon‐mediated repression of miR‐324‐5p potentiates necroptosis to facilitate antiviral defense
por: Dou, Xiaoyan, et al.
Publicado: (2022)

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p
por: Liu, Haiyan, et al.
Publicado: (2019)

Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification
por: Wang, Chan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jo277ojn6l6n2kj4iplor4n42l